Daria Zdżalik-Bielecka

Has grant

ASSISTANT PROFESSOR

University of Warsaw, Faculty of Biology

Poland

Research Interests

Explore related searches

Professors in Poland Professors in Cancer Biology Cancer Biology professors in Poland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Daria Zdżalik-Bielecka is an Assistant Professor at the University of Warsaw, Faculty of Biology, Poland. Her research focuses on the intersection of immunology and oncology, particularly in relation to receptor TAM and fibroblast growth factor receptors. Recent articles highlight her work on selective inhibitors for various forms of cancer and the mechanisms of cancer cell invasion and signaling pathways.

Recent Grants

Grant: Close

Endocytosis of AXL receptor and its role in AXL-mediated signaling

Open Date: 2016-01-01

Close Date: 2020-01-01

Articles (9)

Year:

2025

Year:

2024

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Collaborators (5)

Konrad Kosicki

Assistant Professor

University of Warsaw, Faculty of Biology

POLAND

View details

Jolanta Czerwinska

University of Warsaw

POLAND

View details

Katarzyna Piwocka

Professor of the Nencki Institute of Experimental Biology, Polsh Academy of Sciences

Nencki Institute of Experimental Biology

POLAND

View details

Marta Miaczynska

International Institute of Molecular and Cell Biology

POLAND

View details

Speina Elzbieta

Institute of Biochemistry and Biophysics, Polish Academy of Sciences

POLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Daria Zdżalik-Bielecka

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (9)

Na skrzyżowaniu immunologii i onkologii: receptory TAM w regulacji odpowiedzi immunologicznej i procesów związanych z nowotworzeniem

Preclinical characterization of CPL304110 as a potent and selective inhibitor of fibroblast growth factor receptors 1, 2, and 3 for gastric, bladder, and squamous cell lung cancer.

Endocytic trafficking of GAS6–AXL complexes is associated with sustained AKT activation

Design, Synthesis, and Development of pyrazolo[1,5-a]pyrimidine Derivatives as a Novel Series of Selective PI3Kδ Inhibitors: Part I—Indole Derivatives

Design, Synthesis, and Development of Pyrazolo[1,5-a]pyrimidine Derivatives as a Novel Series of Selective PI3Kδ Inhibitors: Part II—Benzimidazole Derivatives

Bemcentinib and Gilteritinib Inhibit Cell Growth and Impair the Endo-Lysosomal and Autophagy Systems in an AXL-Independent Manner

The GAS6-AXL signaling pathway triggers actin remodeling that drives membrane ruffling, macropinocytosis, and cancer-cell invasion

Discovery and optimization of novel pyrazole-benzimidazole CPL304110, as a potent and selective inhibitor of fibroblast growth factor receptors FGFR (1–3)

DNA damage, repair and the improvement of cancer therapy – A tribute to the life and research of Barbara Tudekz

Collaborators (5)

Konrad Kosicki

Jolanta Czerwinska

Katarzyna Piwocka

Marta Miaczynska

Speina Elzbieta

Make your next move.